{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:55:52Z","timestamp":1790780152782,"version":"4.1.0"},"posted":{"date-parts":[[2026,6,10]]},"group-title":"Genetics","reference-count":44,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"award":["AR070879"],"award-info":[{"award-number":["AR070879"]}],"id":[{"id":"https:\/\/ror.org\/006zn3t30","id-type":"ROR","asserted-by":"publisher"}]},{"award":["R25HG012919"],"award-info":[{"award-number":["R25HG012919"]}],"id":[{"id":"https:\/\/ror.org\/00baak391","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,9,25]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:p>Teriparatide (PTH 1-34) is an anabolic agent used to treat osteoporosis, yet clinical response varies widely among patients. To investigate genetic and sex-specific determinants of skeletal response, we administered intermittent PTH to male and female mice from eight genetically diverse inbred strains. Mice were treated for four weeks, and bone phenotypes were assessed via DXA, microCT, and mechanical testing. Response to PTH was highly strain- and sex-dependent, with some strains responding at the femur but not the spine, and vice versa. Heritability estimates for PTH-induced changes in areal bone mineral density (aBMD), cortical bone area at the femoral mid-diaphysis, femur strength, and trabecular bone volume fraction (BV\/TV) ranged from moderate to high, with BV\/TV showing the strongest genetic influence. Cortical bone response mechanisms differed by sex: males exhibited periosteal expansion, while females showed endosteal remodeling. These findings mirror clinical observations where non-response to PTH can be anatomic site specific. Further, our study suggests that genetic background and sex significantly influence bone response to PTH. Our data support the future use of genetically diverse mouse models to elucidate the genetic architecture of skeletal response to PTH.<\/jats:p>\n                <jats:sec>\n                  <jats:title>Highlights<\/jats:title>\n                  <jats:list list-type=\"bullet\">\n                    <jats:list-item>\n                      <jats:p>PTH response varied by genetics, sex, and skeletal site (femur vs spine).<\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>Trabecular bone volume showed the strongest genetic effect (heritability) with PTH treatment.<\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>Response to PTH was sex-specific.<\/jats:p>\n                    <\/jats:list-item>\n                  <\/jats:list>\n                <\/jats:sec>","DOI":"10.64898\/2026.06.09.729629","type":"posted-content","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T02:30:16Z","timestamp":1781145016000},"source":"Crossref","is-referenced-by-count":0,"title":["Bone response to intermittent parathyroid hormone (PTH) is both genetic and sex specific in mice"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6090-0516","authenticated-orcid":false,"given":"Douglas J.","family":"Adams","sequence":"first","affiliation":[{"name":"Department of Orthopedics, University of Colorado School of Medicine, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana A.","family":"Godfrey","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, University of Colorado School of Medicine, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane E.","family":"Ridoux","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, University of Colorado School of Medicine, Aurora, CO"},{"name":"Department of Biomedical Informatics, University of Colorado, Aurora, CO"},{"name":"Department of Mathematical and Statistical Sciences, University of Colorado, Denver, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Maynard","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, University of Colorado School of Medicine, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole S.","family":"Szeto","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, University of Colorado School of Medicine, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7075-4287","authenticated-orcid":false,"given":"Ethan M.","family":"Lange","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, University of Colorado, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4253-4775","authenticated-orcid":false,"given":"Cheryl L.","family":"Ackert-Bicknell","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, University of Colorado School of Medicine, Aurora, CO"},{"name":"Department of Biomedical Informatics, University of Colorado, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026093007050491000_2026.06.09.729629v2.1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020334"},{"issue":"4","key":"2026093007050491000_2026.06.09.729629v2.2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ecl.2024.08.003","article-title":"Latest on Anabolic Agents for Osteoporosis Treatment","volume":"53","year":"2024","journal-title":"Endocrinol. Metab. Clin. North Am"},{"issue":"6","key":"2026093007050491000_2026.06.09.729629v2.3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1742-7843.2004.pto940602.x","article-title":"Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis","volume":"94","year":"2004","journal-title":"Basic Clin. Pharmacol. Toxicol"},{"issue":"10","key":"2026093007050491000_2026.06.09.729629v2.4","doi-asserted-by":"crossref","first-page":"e10800","DOI":"10.1002\/jbm4.10800","article-title":"Anabolic and Antiresorptive Osteoporosis Treatment: Trends, Costs, and Sequence in a Commercially Insured Population, 2003-2021","volume":"7","year":"2023","journal-title":"JBMR Plus"},{"issue":"12","key":"2026093007050491000_2026.06.09.729629v2.5","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/jbmr.1768","article-title":"The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years","volume":"27","year":"2012","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res"},{"key":"2026093007050491000_2026.06.09.729629v2.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2006.06.007"},{"issue":"6","key":"2026093007050491000_2026.06.09.729629v2.7","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00198-010-1376-1","article-title":"Variability in the measured response of bone to teriparatide","volume":"22","year":"2011","journal-title":"Osteoporos. Int. J. Establ. Result Coop. Eur. Found. Osteoporos. Natl. Osteoporos. Found. USA"},{"key":"2026093007050491000_2026.06.09.729629v2.8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bonr.2015.11.001","article-title":"Predictors of teriparatide treatment failure in patients with low bone mass","volume":"4","year":"2016","journal-title":"Bone Rep"},{"issue":"3","key":"2026093007050491000_2026.06.09.729629v2.9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/07435800.2018.1454461","article-title":"Skeletal response to treatment with teriparatide (TPD) after bisphosphonate in post-menopausal women with osteoporosis and a high prevalence of secondary risk factors in real-life setting of a metabolic bone clinic; effect of age and vitamin D status","volume":"43","year":"2018","journal-title":"Endocr. Res"},{"issue":"3","key":"2026093007050491000_2026.06.09.729629v2.10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11914-013-0151-6","article-title":"Impact of the environment on the skeleton: is it modulated by genetic factors?","volume":"11","year":"2013","journal-title":"Curr. Osteoporos. Rep"},{"issue":"7","key":"2026093007050491000_2026.06.09.729629v2.11","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1136\/ard-2022-223618","article-title":"Genome-wide association study identifies genetic variants which predict the response of bone mineral density to teriparatide therapy","volume":"82","year":"2023","journal-title":"Ann. Rheum. Dis"},{"key":"2026093007050491000_2026.06.09.729629v2.12","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.20398"},{"key":"2026093007050491000_2026.06.09.729629v2.13","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwx227"},{"key":"2026093007050491000_2026.06.09.729629v2.14","doi-asserted-by":"publisher","DOI":"10.1007\/s00335-012-9414-2"},{"key":"2026093007050491000_2026.06.09.729629v2.15","doi-asserted-by":"publisher","DOI":"10.1038\/ng1104-1133"},{"key":"2026093007050491000_2026.06.09.729629v2.16","unstructured":"Silver LM. Mouse Genetics: Concepts and Applications [Internet]. 1st ed. Oxford University Press; 1995. Available from: https:\/\/www.informatics.jax.org\/silver\/contents.shtml"},{"key":"2026093007050491000_2026.06.09.729629v2.17","unstructured":"The Jackson Laboratory handbook on genetically standardized mice - National Institutes of Health [Internet]. [cited 2026 Aug 24]. Available from: https:\/\/onesearch.nihlibrary.ors.nih.gov\/discovery\/fulldisplay\/alma991000558099704686\/01NIH_INST:NIH"},{"key":"2026093007050491000_2026.06.09.729629v2.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2008.04.012"},{"key":"2026093007050491000_2026.06.09.729629v2.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2007.11.017"},{"issue":"2","key":"2026093007050491000_2026.06.09.729629v2.20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bone.2006.09.010","article-title":"Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity","volume":"40","year":"2007","journal-title":"Bone"},{"key":"2026093007050491000_2026.06.09.729629v2.21","doi-asserted-by":"crossref","unstructured":"Hendesi H , Godfrey DA , Ruble AF , Tran AM , Villani DA , Landgrave SH , Hasan NA , Adams DJ , Zuscik MJ . Intermittent fasting alleviates obesity-associated impairments in bone fracture healing: Exploring the role of gut microbiome. Bone Rep. 2025 Dec;27:101876.","DOI":"10.1016\/j.bonr.2025.101876"},{"issue":"8","key":"2026093007050491000_2026.06.09.729629v2.22","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/jbmr\/zjag001","article-title":"IRE1 signaling in osteoprogenitors augments \u03b2-catenin activity and physiologic bone accrual","volume":"41","year":"2026","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res"},{"key":"2026093007050491000_2026.06.09.729629v2.23","doi-asserted-by":"crossref","first-page":"101911","DOI":"10.1016\/j.bonr.2026.101911","article-title":"Demystifying machine learning approaches in digital bone imaging using microCT and HRpQCT","volume":"29","year":"2026","journal-title":"Bone Rep"},{"key":"2026093007050491000_2026.06.09.729629v2.24","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-018-0421-4"},{"key":"2026093007050491000_2026.06.09.729629v2.25","doi-asserted-by":"publisher","DOI":"10.1101\/gr.113886.110"},{"issue":"9","key":"2026093007050491000_2026.06.09.729629v2.26","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1534\/g3.114.013748","article-title":"Quantitative Trait Locus Mapping Methods for Diversity Outbred Mice","volume":"4","year":"2014","journal-title":"G3 GenesGenomesGenetics"},{"issue":"8","key":"2026093007050491000_2026.06.09.729629v2.27","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.3390\/genes13081472","article-title":"Analysis of Common SNPs across Continents Reveals Major Genomic Differences between Human Populations","volume":"13","year":"2022","journal-title":"Genes"},{"issue":"3","key":"2026093007050491000_2026.06.09.729629v2.28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/jpm9030040","article-title":"Pharmacogenomic Testing: Clinical Evidence and Implementation Challenges","volume":"9","year":"2019","journal-title":"J. Pers. Med"},{"issue":"1","key":"2026093007050491000_2026.06.09.729629v2.29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40520-025-02972-2","article-title":"Treatment failure in osteoporosis: who will experience a new Fracture? TAILOR a retrospective study","volume":"37","year":"2025","journal-title":"Aging Clin. Exp. Res"},{"issue":"12","key":"2026093007050491000_2026.06.09.729629v2.30","first-page":"2769","article-title":"IOF CSA Inadequate Responders Working Group","volume":"23","year":"2012","journal-title":"Treatment failure in osteoporosis. Osteoporos. Int. J. Establ. Result Coop. Eur. Found. Osteoporos. Natl. Osteoporos. Found. USA"},{"issue":"2","key":"2026093007050491000_2026.06.09.729629v2.31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/jbmr.563","article-title":"Genome-wide association of an integrated osteoporosis-related phenotype: is there evidence for pleiotropic genes?","volume":"27","year":"2012","journal-title":"J. Bone Miner. Res"},{"key":"2026093007050491000_2026.06.09.729629v2.32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2406"},{"issue":"7","key":"2026093007050491000_2026.06.09.729629v2.33","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1210\/jc.2014-1041","article-title":"Teriparatide increases strength of the peripheral skeleton in premenopausal women with idiopathic osteoporosis: a pilot HR-pQCT study","volume":"99","year":"2014","journal-title":"J. Clin. Endocrinol. Metab"},{"issue":"1","key":"2026093007050491000_2026.06.09.729629v2.34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jbmr.2315","article-title":"Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT Study","volume":"30","year":"2015","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res"},{"issue":"1","key":"2026093007050491000_2026.06.09.729629v2.35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1359\/jbmr.2003.18.1.9","article-title":"The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis","volume":"18","year":"2003","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res"},{"issue":"4","key":"2026093007050491000_2026.06.09.729629v2.36","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00198-014-3001-1","article-title":"Analysis of daily teriparatide treatment for osteoporosis in men","volume":"26","year":"2015","journal-title":"Osteoporos. Int. J. Establ. Result Coop. Eur. Found. Osteoporos. Natl. Osteoporos. Found. USA"},{"issue":"6","key":"2026093007050491000_2026.06.09.729629v2.37","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.tem.2024.01.004","article-title":"A perspective on muscle phenotyping in musculoskeletal research","volume":"35","year":"2024","journal-title":"Trends Endocrinol. Metab. TEM"},{"issue":"10","key":"2026093007050491000_2026.06.09.729629v2.38","doi-asserted-by":"crossref","first-page":"bvae153","DOI":"10.1210\/jendso\/bvae153","article-title":"Sexual Dimorphism in the Musculoskeletal System: Sex Hormones and Beyond","volume":"8","year":"2024","journal-title":"J. Endocr. Soc"},{"key":"2026093007050491000_2026.06.09.729629v2.39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105103441904"},{"key":"2026093007050491000_2026.06.09.729629v2.40","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.mce.2018.06.011","article-title":"Site-specific differences in osteoblast phenotype, mechanical loading response and estrogen receptor-related gene expression","volume":"477","year":"2018","journal-title":"Mol. Cell. Endocrinol"},{"issue":"1","key":"2026093007050491000_2026.06.09.729629v2.41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00198-012-2159-7","article-title":"Effects of a single injection of teriparatide on bone turnover markers in postmenopausal women","volume":"24","year":"2013","journal-title":"Osteoporos. Int"},{"key":"2026093007050491000_2026.06.09.729629v2.42","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-018-0421-4"},{"issue":"1","key":"2026093007050491000_2026.06.09.729629v2.43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1359\/jbmr.1999.14.1.39","article-title":"Osteoclast formation in bone marrow cultures from two inbred strains of mice with different bone densities","volume":"14","year":"1999","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res"},{"key":"2026093007050491000_2026.06.09.729629v2.44","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-010-1226-1"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.06.09.729629","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:05:18Z","timestamp":1790777118000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.06.09.729629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":44,"URL":"https:\/\/doi.org\/10.64898\/2026.06.09.729629","relation":{},"subject":[],"published":{"date-parts":[[2026,6,10]]},"subtype":"preprint"}}